Ranexa has been studied in multiple clinical trials. The pivotal Phase 3 CARISA trial established the efficacy of Ranexa in treating chronic angina. The TERISA trial assessed Ranexa in patients with chronic angina and type 2 diabetes.
See how Ranexa affected exercise duration, angina symptoms and nitroglycerin use when added to background antianginal therapy.Learn More
Learn about Ranexa's effects on angina frequency and nitroglycerin use in patients with chronic angina and type 2 diabetes in the TERISA trial.View the Data